Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
- PMID: 24045657
- PMCID: PMC3817322
- DOI: 10.1038/bjc.2013.566
Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'
Comment in
-
Reply: 'Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'.Br J Cancer. 2013 Oct 29;109(9):2503-4. doi: 10.1038/bjc.2013.567. Epub 2013 Sep 17. Br J Cancer. 2013. PMID: 24045664 Free PMC article. No abstract available.
Comment on
-
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors.Br J Cancer. 2013 Jul 9;109(1):60-7. doi: 10.1038/bjc.2013.226. Epub 2013 May 9. Br J Cancer. 2013. PMID: 23660945 Free PMC article.
References
-
- Cooney MT, Dudina A, D'Aogstino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future. Circulation. 2010;122:300–310. - PubMed
-
- de Haas EC, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker JL, van Roon AM, Postma A, Wolffenbuttel BHR, Hoekstra HJ, van Leeuwen FE, Sleijfer DT, Gietema JA. Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol. 2013;24:749–755. - PubMed
-
- Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, Montori VM. Metabolic syndrome and the risk of incident cardiovascular events and death: a systematic reviewand meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49:403–414. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
